4D Molecular Therapeutics Inc. (FDMT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
4:30 pm
Sale
2026-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
RA CAPITAL MANAGEMENT L.P.5,105,622
9.900%
-608,230decrease
(-10.64%)
Filing
History
2026-05-15
4:08 pm
Sale
2026-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
BIOTECHNOLOGY VALUE FUND L P5,346,519
9.990%
-500,762decrease
(-8.56%)
Filing
History
2026-05-12
09:42 am
Purchase
2026-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
STATE STREET CORP
STT
2,707,875
5.300%
2,707,875increase
(New Position)
Filing
History
2026-04-07
3:48 pm
Purchase
2026-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
JANUS HENDERSON GROUP Ltd.
JHG
5,247,151
10.300%
611,276increase
(+13.19%)
Filing
History
2026-03-26
09:02 am
Sale
2026-03-1313G4D MOLECULAR THERAPEUTICS INC.
FDMT
VANGUARD GROUP INC0
0.000%
-2,767,717decrease
(Position Closed)
Filing
History
2026-02-17
6:55 pm
Purchase
2025-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
Novo Holdings A/S3,650,737
6.400%
475,737increase
(+14.98%)
Filing
History
2026-02-17
4:15 pm
Purchase
2025-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
RA CAPITAL MANAGEMENT L.P.5,713,852
9.900%
1,148,985increase
(+25.17%)
Filing
History
2026-02-17
4:12 pm
Purchase
2025-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
BIOTECHNOLOGY VALUE FUND L P5,847,281
9.990%
1,214,532increase
(+26.22%)
Filing
History
2026-02-17
12:42 pm
Purchase
2025-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
JANUS HENDERSON GROUP Ltd.
JHG
4,635,875
8.100%
2,383,635increase
(+105.83%)
Filing
History
2026-02-09
4:05 pm
Sale
2025-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
GOLDMAN SACHS GROUP INC
GS
4,286,077
7.500%
-137,358decrease
(-3.11%)
Filing
History
2025-10-20
5:12 pm
Purchase
2025-10-1313G4D MOLECULAR THERAPEUTICS INC.
FDMT
Novo Holdings A/S3,175,000
6.800%
3,175,000increase
(New Position)
Filing
History
2025-10-17
6:13 pm
Sale
2025-09-3013G4D MOLECULAR THERAPEUTICS INC.
FDMT
BlackRock Inc.
BLK
3,062,596
6.600%
-552,720decrease
(-15.29%)
Filing
History
2025-05-15
5:44 pm
Sale
2025-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
Venrock Healthcare Capital Partners III, L.P.677,600
1.500%
-2,274,771decrease
(-77.05%)
Filing
History
2025-05-15
4:29 pm
Sale
2025-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
BIOTECHNOLOGY VALUE FUND L P4,632,749
9.990%
-201,548decrease
(-4.17%)
Filing
History
2025-04-17
09:35 am
Sale
2025-03-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
BlackRock Inc.
BLK
3,615,316
7.800%
-1,349,703decrease
(-27.18%)
Filing
History
2025-02-14
6:30 pm
Sale
2024-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
RA CAPITAL MANAGEMENT L.P.4,564,867
9.900%
-533,344decrease
(-10.46%)
Filing
History
2025-02-14
6:09 pm
Sale
2024-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
Venrock Healthcare Capital Partners III, L.P.2,952,371
6.400%
-1,447,629decrease
(-32.90%)
Filing
History
2025-02-14
4:20 pm
Sale
2024-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
BIOTECHNOLOGY VALUE FUND L P4,834,297
9.990%
-2,548,345decrease
(-34.52%)
Filing
History
2025-02-14
11:34 am
Sale
2024-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
JANUS HENDERSON GROUP Ltd.
JHG
2,252,240
4.900%
-884,847decrease
(-28.21%)
Filing
History
2025-02-14
08:40 am
Sale
2024-12-3113G4D MOLECULAR THERAPEUTICS INC.
FDMT
Deep Track Capital, LP609,900
1.320%
-3,486,552decrease
(-85.11%)
Filing
History
Goto 0, 1, 2, Next